| Title : The antioxidant 2,3-dichloro,5,8-dihydroxy,1,4-naphthoquinone inhibits acetyl-cholinesterase activity and amyloid beta(42) aggregation: A dual target therapeutic candidate compound for the treatment of Alzheimer's disease - Khelifi_2020_Biotechnol.Appl.Biochem_67_983 |
| Author(s) : Khelifi I , Tourrette A , Dhouafli Z , Bouajila J , Efferth T , Abdelfatah S , Ksouri R , Hayouni EA |
| Ref : Biotechnol Appl Biochem , 67 :983 , 2020 |
| Abstract : Khelifi_2020_Biotechnol.Appl.Biochem_67_983 |
| ESTHER : Khelifi_2020_Biotechnol.Appl.Biochem_67_983 |
| PubMedSearch : Khelifi_2020_Biotechnol.Appl.Biochem_67_983 |
| PubMedID: 31820491 |
Khelifi I, Tourrette A, Dhouafli Z, Bouajila J, Efferth T, Abdelfatah S, Ksouri R, Hayouni EA (2020)
The antioxidant 2,3-dichloro,5,8-dihydroxy,1,4-naphthoquinone inhibits acetyl-cholinesterase activity and amyloid beta(42) aggregation: A dual target therapeutic candidate compound for the treatment of Alzheimer's disease
Biotechnol Appl Biochem
67 :983
Khelifi I, Tourrette A, Dhouafli Z, Bouajila J, Efferth T, Abdelfatah S, Ksouri R, Hayouni EA (2020)
Biotechnol Appl Biochem
67 :983